Utilization of Apixaban Pharmacokinetics for Dose Optimization in High-Risk Elderly Patients. - Goldstein R; Sandouka K; Zighan L; Ya'ari S; Bialer M; Muszkat M (Clinical pharmacokinetics, 2026)